[go: up one dir, main page]

DK1603573T3 - Anvendelse af dipyridamol i kombination med acetylsalicylsyre og en angiotensin II-antagonist til forebyggelse af slagtilfælde - Google Patents

Anvendelse af dipyridamol i kombination med acetylsalicylsyre og en angiotensin II-antagonist til forebyggelse af slagtilfælde

Info

Publication number
DK1603573T3
DK1603573T3 DK04709596T DK04709596T DK1603573T3 DK 1603573 T3 DK1603573 T3 DK 1603573T3 DK 04709596 T DK04709596 T DK 04709596T DK 04709596 T DK04709596 T DK 04709596T DK 1603573 T3 DK1603573 T3 DK 1603573T3
Authority
DK
Denmark
Prior art keywords
dipyridamole
angiotensin
antagonist
combination
acetylsalicylic acid
Prior art date
Application number
DK04709596T
Other languages
Danish (da)
English (en)
Inventor
James C Gilbert
Axel Riedel
Lutz Hilbrich
David Michael Humphreys
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32870338&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1603573(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Application granted granted Critical
Publication of DK1603573T3 publication Critical patent/DK1603573T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK04709596T 2003-02-13 2004-02-10 Anvendelse af dipyridamol i kombination med acetylsalicylsyre og en angiotensin II-antagonist til forebyggelse af slagtilfælde DK1603573T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10306179A DE10306179A1 (de) 2003-02-13 2003-02-13 Verwendung von Dipyridamol in Kombination mit Acetylsalicylsäure und einem Angiotensin II-Antagonisten zur Schlaganfall-Prophylaxe
EP03018212 2003-08-08
PCT/EP2004/001208 WO2004071385A2 (fr) 2003-02-13 2004-02-10 Utilisation de dipyridamole en association avec de l'acide acetylsalicylique et un antagoniste de l'angiotensine ii aux fins de la prevention des accidents cerebro-vasculaires

Publications (1)

Publication Number Publication Date
DK1603573T3 true DK1603573T3 (da) 2008-09-15

Family

ID=32870338

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04709596T DK1603573T3 (da) 2003-02-13 2004-02-10 Anvendelse af dipyridamol i kombination med acetylsalicylsyre og en angiotensin II-antagonist til forebyggelse af slagtilfælde

Country Status (29)

Country Link
US (5) US20040214802A1 (fr)
EP (2) EP1603573B8 (fr)
JP (1) JP2006517557A (fr)
KR (1) KR20050100676A (fr)
CN (1) CN1750830A (fr)
AR (1) AR043173A1 (fr)
AT (1) ATE395921T1 (fr)
AU (1) AU2004212305A1 (fr)
BR (1) BRPI0407457A (fr)
CA (1) CA2515941A1 (fr)
DE (2) DE10306179A1 (fr)
DK (1) DK1603573T3 (fr)
EA (1) EA200501231A1 (fr)
EC (1) ECSP055963A (fr)
ES (1) ES2308147T3 (fr)
HR (1) HRP20050713A2 (fr)
MX (1) MXPA05008572A (fr)
NO (1) NO20054216L (fr)
NZ (1) NZ542302A (fr)
PE (1) PE20050191A1 (fr)
PL (1) PL378204A1 (fr)
PT (1) PT1603573E (fr)
RS (1) RS20050618A (fr)
SI (1) SI1603573T1 (fr)
TW (1) TW200501957A (fr)
UA (1) UA83481C2 (fr)
UY (1) UY28182A1 (fr)
WO (1) WO2004071385A2 (fr)
ZA (1) ZA200505956B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10335027A1 (de) * 2003-07-31 2005-02-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Angiotensin II Rezeptor Antagonisten
DE10306179A1 (de) * 2003-02-13 2004-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Dipyridamol in Kombination mit Acetylsalicylsäure und einem Angiotensin II-Antagonisten zur Schlaganfall-Prophylaxe
CA2437709A1 (fr) * 2003-08-08 2005-02-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Utilisation de dipyridamole, d'acide acetylsalicylique et d'un antagoniste de l'angiotensine ii pour le traitement et la prevention de troubles vasculaires
JP2005060359A (ja) * 2003-08-13 2005-03-10 Boehringer Ingelheim Pharma Gmbh & Co Kg 血管系病態の治療及び予防のためのジピリダモール、アセチルサリチル酸及びアンギオテンシンｉｉ拮抗薬の使用
WO2009080301A1 (fr) * 2007-12-21 2009-07-02 Boehringer Ingelheim International Gmbh Traitement et prévention des lésions cérébrales ischémiques et des troubles cognitifs cérébrovasculaires, au moyen d'un régime de traitement composé de dipyridamole et d'un bloqueur du récepteur de l'angiotensine ii, chez des patients ayant subi un accident cérébrovasculaire
US20100069326A1 (en) * 2008-02-14 2010-03-18 Wasimul Haque Combination Therapies to Treat Cardio- and Cerebro-Vascular Disorders
WO2009100534A1 (fr) * 2008-02-14 2009-08-20 Kardiatech, Inc. Thérapie de combinaison pour traiter des troubles vasculaires
WO2010097501A2 (fr) * 2009-02-26 2010-09-02 Orion Corporation Traitement combiné
US8633158B1 (en) * 2012-10-02 2014-01-21 Tarix Pharmaceuticals Ltd. Angiotensin in treating brain conditions
CN107106541A (zh) 2015-01-28 2017-08-29 瑞采生技有限公司 用于增强PPARγ表现及核转位之化合物及其医疗用途

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3031458A (en) * 1958-02-05 1962-04-24 Ciba Pharm Prod Inc Isoindolines
US3031450A (en) 1959-04-30 1962-04-24 Thomae Gmbh Dr K Substituted pyrimido-[5, 4-d]-pyrimidines
US3317279A (en) * 1963-03-15 1967-05-02 Pennsalt Chemicals Corp Polymorph of calcium disilicide and its method of preparation
JPS5671074A (en) * 1979-11-12 1981-06-13 Takeda Chem Ind Ltd 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative
DE3000979A1 (de) 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
US4318477A (en) * 1980-09-22 1982-03-09 Kerpe Stase Z Pharmaceutical package
DE3124090A1 (de) 1981-06-19 1983-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale dipyridamolformen
CA1334092C (fr) 1986-07-11 1995-01-24 David John Carini Imidazoles bloquant les recepteurs de l'angiotensine ii
DE3627423A1 (de) 1986-08-13 1988-02-18 Thomae Gmbh Dr K Arzneimittel enthaltend dipyridamol oder mopidamol und o-acetylsalicylsaeure bzw. deren physiologisch vertraegliche salze, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung der thrombusbildung
US5015651A (en) 1988-01-07 1991-05-14 E. I. Du Pont De Nemours And Company Treatment of hypertension with 1,2,4-angiotensin II antagonists
CA1338238C (fr) 1988-01-07 1996-04-09 David John Carini Imidazoles bloquant les recepteurs de l'angiotensine ii et combinaisons de ces imidazoles avec des diuretiques et des anti-inflammatoires non steroidiens
US4880804A (en) * 1988-01-07 1989-11-14 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking benzimidazoles
SI9210098B (sl) 1991-02-06 2000-06-30 Dr. Karl Thomae Benzimidazoli, zdravila, ki te spojine vsebujejo, in postopek za njihovo pripravo
EP1013273A1 (fr) 1998-12-23 2000-06-28 Novartis AG Utilisation des antagonistes du recepteur AT-1 ou des modulateurs du recepteur AT-2 pour le traitement de maladies asocciées à une augmentation de recepteurs AT-1 ou AT-2
SE9903028D0 (sv) * 1999-08-27 1999-08-27 Astra Ab New use
EP1093814A1 (fr) * 1999-10-22 2001-04-25 Boehringer Ingelheim Pharma KG Utilisation du dipyridamole ou du mopidamol dans la fabrication d'un médicament pour le traitement et la prévention des troubles de la microcirculation dépendants de la fibrine
JP2002138054A (ja) * 2000-08-25 2002-05-14 Takeda Chem Ind Ltd フィブリノーゲン低下剤
JP2002293742A (ja) * 2001-01-29 2002-10-09 Takeda Chem Ind Ltd 鎮痛・抗炎症剤
JP2003212758A (ja) * 2001-03-16 2003-07-30 Takeda Chem Ind Ltd 徐放性製剤の製造法
DE10306179A1 (de) * 2003-02-13 2004-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Dipyridamol in Kombination mit Acetylsalicylsäure und einem Angiotensin II-Antagonisten zur Schlaganfall-Prophylaxe

Also Published As

Publication number Publication date
JP2006517557A (ja) 2006-07-27
EP1733729A1 (fr) 2006-12-20
EP1603573B1 (fr) 2008-05-21
CN1750830A (zh) 2006-03-22
ECSP055963A (es) 2006-01-16
DE10306179A1 (de) 2004-08-26
UA83481C2 (uk) 2008-07-25
HRP20050713A2 (en) 2006-09-30
SI1603573T1 (sl) 2008-10-31
WO2004071385A2 (fr) 2004-08-26
PE20050191A1 (es) 2005-04-12
ES2308147T3 (es) 2008-12-01
MXPA05008572A (es) 2005-11-04
US20060241089A1 (en) 2006-10-26
PL378204A1 (pl) 2006-03-20
US20080188497A1 (en) 2008-08-07
KR20050100676A (ko) 2005-10-19
RS20050618A (sr) 2007-09-21
US20040214802A1 (en) 2004-10-28
EP1603573A2 (fr) 2005-12-14
ATE395921T1 (de) 2008-06-15
EA200501231A1 (ru) 2006-02-24
PT1603573E (pt) 2008-06-26
EP1603573B8 (fr) 2009-04-01
US20070004687A1 (en) 2007-01-04
CA2515941A1 (fr) 2004-08-26
NO20054216D0 (no) 2005-09-12
TW200501957A (en) 2005-01-16
NZ542302A (en) 2008-12-24
DE602004013937D1 (de) 2008-07-03
BRPI0407457A (pt) 2006-01-31
US20080113949A1 (en) 2008-05-15
NO20054216L (no) 2005-09-12
WO2004071385A3 (fr) 2005-01-06
AU2004212305A1 (en) 2004-08-26
AR043173A1 (es) 2005-07-20
ZA200505956B (en) 2006-03-29
UY28182A1 (es) 2004-09-30

Similar Documents

Publication Publication Date Title
DK1891973T3 (da) Kombinationer omfattende antimuskarine midler og PDE4-hæmmere
DE602005012825D1 (de) Diphenylimidazopyrimidin- und -imidazolamine als b-sekretase-inhibitoren
LTC1761540I2 (lt) Chinazolinonai kaip žmogaus fosfatidilinozitol-3-kinazės-delta inhibitoriai
ATE435859T1 (de) Gyraseinhibitoren und deren verwendungen
IS7700A (is) Ný spíróþétt kínasólínón og notkun þeirra sem fosfórdíesterasa hindrar
DK1531819T3 (da) Anvendelse af ikappab kinaseinhibitorer i smertebehandlingen
HRP20160880T1 (hr) Formulacija obložene tablete i postupak
DK3366283T3 (da) Direkte sammenpresningsformulering og fremgangsmåde
EP1827389A4 (fr) Compositions a nanoparticules a liberation prolongee et procedes d'utilisation
EP1653970A4 (fr) Inhibiteurs de gsk-3 et utilisations
DK1597238T3 (da) HIV-replicationshæmmende pyrimidiner og triaziner
DK1583542T3 (da) Sammensætninger og fremgangsmåder til antiviral kombinationsterapi
DK1765793T3 (da) Anacetrapib og andre cetp-inhibitorer
EP1694821A4 (fr) Reconstruction probable de surfaces dans des regions occluses par symetrie calculee
EP1490373A4 (fr) Inhibiteurs des nucleoside phosphorylases et nucleosidases
NO20054969D0 (no) 2-cyanopropansyreamid- og esterderivater og deres anvendelse
IS8597A (is) Samsetningar rísedrónats og aðferðir við notkun þess
DK1603573T3 (da) Anvendelse af dipyridamol i kombination med acetylsalicylsyre og en angiotensin II-antagonist til forebyggelse af slagtilfælde
DK1626736T3 (da) C1-inhibitor med kort halveringstid til midlertidig behandling
DK1829874T3 (da) Tricyklisk forbindelse og anvendelse deraf
EP1688126A4 (fr) Inhibiteurs de parakeratose et composition externe cutanee
ITRM20040058A1 (it) Inibitori ed antagonisti di hmgb1 in grado di regolare la proliferazione delle cellule muscolari lisce ed endoteliali.
DK1882054T3 (da) Korrosionsbeskyttelsesanordning og fremgangsmåde
DK1840121T3 (da) Glycinderivat og anvendelse heraf
IL178970A0 (en) Haplotype markers and methods of using the same to determine response to treatment